Tocqueville Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-770	Closed	-$224K	–	676
2020 Q2	$224K	Sell	770 -1,500	-66%	-$407K	﹤0.01%	613
2020 Q1	$540K	Buy	2,270 +725	+47%	+$166K	0.01%	441
2019 Q4	$338K	Buy	+1,545	New	+$313K	0.01%	626
2019 Q2	–	Sell	-15,110	Closed	-$2.78M	–	804
2019 Q1	$2.78M	Buy	15,110 +2,275	+18%	+$420K	0.04%	348
2018 Q4	$2.13M	Sell	12,835 -28,180	-69%	-$4.88M	0.03%	375
2018 Q3	$7.91M	Buy	41,015 +2,775	+7%	+$494K	0.1%	221
2018 Q2	$6.5M	Sell	38,240 -3,165	-8%	-$491K	0.08%	246
2018 Q1	$6.75M	Sell	41,405 -611	-1%	-$99.8K	0.09%	239
2017 Q4	$6.3M	Buy	42,016 +40,640	+2,953%	+$6.02M	0.07%	275
2017 Q3	$209K	Sell	1,376 -200	-13%	-$30.1K	﹤0.01%	764
2017 Q2	$203K	Buy	+1,576	New	+$190K	﹤0.01%	751
2016 Q4	–	Sell	-32,466	Closed	-$2.83M	–	856
2016 Q3	$2.83M	Sell	32,466 -24,565	-43%	-$2.32M	0.03%	367
2016 Q2	$4.91M	Sell	57,031 -1,100	-2%	-$95K	0.06%	294
2016 Q1	$4.62M	Sell	58,131 -6,675	-10%	-$604K	0.06%	290
2015 Q4	$8.15M	Buy	64,806 +2,375	+4%	+$287K	0.11%	211
2015 Q3	$6.5M	Buy	62,431 +7,070	+13%	+$908K	0.09%	254
2015 Q2	$6.84M	Buy	55,361 +645	+1%	+$81.3K	0.08%	259
2015 Q1	$6.46M	Buy	54,716 +100	+0.2%	+$12K	0.08%	277
2014 Q4	$6.49M	Sell	54,616 -1,450	-3%	-$163K	0.07%	280
2014 Q3	$6.3M	Buy	56,066 +500	+0.9%	+$47.6K	0.07%	257
2014 Q2	$5.26M	Sell	55,566 -5,000	-8%	-$351K	0.05%	306
2014 Q1	$4.28M	Sell	60,566 -200	-0.3%	-$15.8K	0.06%	278
2013 Q4	$4.51M	Sell	60,766 -590	-1%	-$41.1K	0.06%	269
2013 Q3	$4.65M	Sell	61,356 -2,050	-3%	-$163K	0.06%	310
2013 Q2	$5.08M	Buy	+63,406	New	+$4.67M	0.07%	277